Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study

Diabetes

Volumn 52, Issue 7, 2003, Pages 1799-1805

  Duncan, Bruce B ^a,b   Schmidt, Maria Inês ^a,b   Pankow, James S ^c   Ballantyne, Christie M ^d   Couper, David ^b   Vigo, Alvaro ^a   Hoogeveen, Ron ^d   Folsom, Aaron R ^c   Heiss, Gerardo ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b IL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; INSULIN; INTERLEUKIN 6; OROSOMUCOID; SIALIC ACID;

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; ETHNOLOGY; FEMALE; GENDER; GENETIC HETEROGENEITY; GLUCOSE BLOOD LEVEL; HAZARD ASSESSMENT; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SMOKING;

EID: 0038691972     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.7.1799     Document Type: Article

References (40)

1. Venkat NK, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F: Diabetes: a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract 50 (Suppl. 2):S77-S84, 2000
2. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 353:1649-1652, 1999
3. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334, 2001
4. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP: The relation of markets of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50:2384-2389, 2001
5. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM: Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25:2016-2021, 2002
6. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58, 2002
7. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA: High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:455-461, 2002
8. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596-1600, 2002
9. Ford ES: Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 155:57-64, 2002
10. Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K: White blood-cell count and the risk of impaired fasting glucose or type II diabetes in middle-aged Japanese men. Diabetologia 45:42-48, 2002
11. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 51:1131-1137, 2002
12. ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 129:687-702, 1989
13. Sugahara K, Sugimoto K, Nomura O, Usui T: Enzymatic assay of serum sialic acid. Clin Chim Acta 108:493-498, 1980
14. Lin DY: On fitting Cox's proportional hazards models to survey data. Biometrika 87:37-47, 2000
15. Barlow WE: Robust variance estimation for the case-cohort design. Biometrics 50:1064-1072, 1994
16. SAS Institute Inc: SAS/STAT Users Guide, Version 8. Cary, NC, SAS Institute, 1999
17. Shah BV, Branwell G, Bieler GS: The SUDAAN User's Manual, Release 7.5. Research Triangle Park, NC, Research Triangle Institute, 2002
18. Lindsay RS, Krakoff J, Hanson RL, Bennett PH, Knowler WC: Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes 50:1598-1603, 2001
19. Trayhurn P, Beattie JH: Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60:329-339, 2001
20. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-614, 1997
21. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE: Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ. Science 293:1673-1677, 2001
22. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS: A central role for JNK in obesity and insulin resistance. Nature 420:333-336, 2002
23. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD: Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97:2601-2610, 1996
24. Wong TY, Klein R, Sharrett AR, Schmidt MI, Pankow JS, Couper DJ, Klein BE, Hubbard LD, Duncan BB: Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287:2528-2533, 2002
25. Marette A: Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 5:377-383, 2002
26. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737, 2002
27. Dandona P, Aljada A, Mohanty P: The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45:924-930, 2002
28. Ferrario M, Carpenter MA, Chambless LE: Reliability of body fat distribution measurements: the ARIC Study baseline cohort results. Atherosclerosis Risk in Communities Study. Int J Obes Relat Metab Disord 19:449-457, 1995
29. Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G: Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults: the ARIC study. Atherosclerosis Risk in Communities. Obes Res 8:279-286, 2000
30. Mochida-Nishimura K, Surewicz K, Cross JV, Hejal R, Templeton D, Rich EA, Toossi Z: Differential activation of MAP kinase signaling pathways and nuclear factor-kappaB in bronchoalveolar cells of smokers and nonsmokers. Mol Med 7:177-185, 2001
31. Heusch WL, Maneckjee R: Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis 19:551-556, 1998
32. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al Abed Y, Czura CJ, Tracey KJ: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384-388, 2003
33. Libert C: Inflammation: a nervous connection. Nature 421:328-329, 2003
34. Sopori M: Effects of cigarette smoke on the immune system. Nat Rev Immunol 2:372-377, 2002
35. Haddy TB, Rana SR, Castro O: Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med 133:15-22, 1999
36. Nieto FJ, Szklo M, Folsom AR, Bock R, Mercun M, for the ARIC Investigators: Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 136:525-537, 1992
37. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G: A metabolic syndrome in whites and African-Americans: the Atherosclerosis Risk in Communities baseline study. Diabetes Care 19:414-418, 1996
38. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R: Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93:1809-1817, 1996
39. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733-739, 1991
40. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072, 2002